Inovio Pharmaceuticals Inc. (INO), a biotechnology company focused on DNA-based immunotherapies and vaccines, is drawing renewed investor attention following a series of clinical and regulatory developments that may shape its strategic trajectory heading into 2026.
DMAb Data Published in Nature Medicine
For comments and feedback contact: editorial@rttnews.com
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.